| # | Drug | Count |
|---|---|---|
| 0 | ACETAMINOPHEN | 57 |
| 1 | METHOTREXATE SODIUM | 51 |
| 2 | FULVESTRANT | 50 |
| 3 | METHOTREXATE | 47 |
| 4 | DOXORUBICIN | 45 |
| 5 | FUROSEMIDE | 45 |
| 6 | ASPIRIN | 44 |
| 7 | ASPIRIN 325 MG | 44 |
| 8 | ASPIRIN 81 MG | 44 |
| 9 | LETROZOLE | 43 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INDIUM IN -111 PENTETREOTIDE | 7 | 0.0547 |
| 1 | ALUMINUM SULFATE TETRADECAHYDRATE, CALCIUM ACETATE MONOHYDRATE | 2 | 0.0312 |
| 2 | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | 4 | 0.0267 |
| 3 | MITAPIVAT | 14 | 0.0105 |
| 4 | BULEVIRTIDE | 1 | 0.0104 |
| 5 | MIRVETUXIMAB SORAVTANSINE | 12 | 0.0066 |
| 6 | PRILOCAINE HYDROCHLORIDE | 1 | 0.0062 |
| 7 | HETASTARCH | 1 | 0.0059 |
| 8 | FLOXURIDINE | 1 | 0.0058 |
| 9 | ODEVIXIBAT | 2 | 0.0050 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 122 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 120 |
| 2 | Kinase Inhibitor [EPC] | 80 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 79 |
| 4 | Proton Pump Inhibitor [EPC] | 76 |
| 5 | Alkylating Drug [EPC] | 70 |
| 6 | Aromatase Inhibitor [EPC] | 68 |
| 7 | Platinum-based Drug [EPC] | 65 |
| 8 | HMG-CoA Reductase Inhibitor [EPC] | 64 |
| 9 | Vitamin C [EPC] | 57 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Pyruvate Kinase Activator [EPC] | 14 | 0.0105 |
| 1 | Ileal Bile Acid Transporter Inhibitor [EPC] | 2 | 0.0044 |
| 2 | Interleukin-6 Antagonist [EPC] | 1 | 0.0015 |
| 3 | CD3-directed Antibody [EPC] | 1 | 0.0014 |
| 4 | Estrogen Receptor Antagonist [EPC] | 51 | 0.0013 |
| 5 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 4 | 0.0012 |
| 6 | Bile Acid [EPC] | 18 | 0.0008 |
| 7 | Complement Inhibitor [EPC] | 42 | 0.0007 |
| 8 | Selectin Blocker [EPC] | 1 | 0.0007 |
| 9 | Aromatase Inhibitor [EPC] | 68 | 0.0006 |